TLR9 and glioblastoma: Previous clinical studies similarly suggest that TLR9 may contribute to the pathogenesis of various types of cancer, where high expression of TLR9 in tumors has been shown to predict decreased survival in patients with glioblastoma multiforme and esophageal cancer (7,8).